openPR Logo
Press release

Prosthetic Heart Valve Market growing at a CAGR of 12.70% by 2024 - Boston Scientific, Boston Scientific Cardiology, CryoLife, Medtronic, Edwards Lifesciences, Symetis, Braile Biomédica, Colibri Heart Valve, Abbott and others

07-23-2018 04:56 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Prosthetic Heart Valve Marke

Global Prosthetic Heart Valve Marke

Prosthetic Heart Valve Market by Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations), Company profiling with detailed strategies, financials, and recent developments. The Global Prosthetic Heart Valve Market report offers a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures.

Market Analysis

The global prosthetic heart valve/ artificial heart valve market accounted to USD 4.53 billion in 2016 growing at a CAGR of 12.70% during the forecast period of 2017 to 2024.e up-coming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Download exclusive PDF sample report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-prosthetic-heart-valve-market

Global Prosthetic Heart Valve Market, By Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Global Prosthetic Heart Valve/ Artificial Heart Valve Market – Market Segmentation:

The global prosthetic heart valve/ artificial heart valve market is segmented on the basis of type.

• Type
• Transcatheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve

On the basis of type, global prosthetic heart valve/ artificial heart valve market is segmented into transcatheter heart valve, tissue heart valve, and mechanical heart valve. Transcatheter heart valves segment is expected to witness the highest market growth in the forecast period (2017-2024) due to use of less invasive techniques, more of technological advancement, increasing number of patients and rising prevalence of aortic stenosis.

Geographical Segmentation:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

On the basis of geography, global prosthetic heart valve/artificial heart valve market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

If you have any special requirements, please let us know and we will offer you the report as you want, Mail us on @ sopan.gedam@databridgemarketresearch.com

FACTORS DRIVING GROWTH IN THE GLOBAL PROSTHETIC HEART VALVE MARKET

Increase in the prevalence of heart value disease and valvular heart disease:

The leading of death in U.S. is heart disease, killing more than 600,000 Americans each year. It was found that each year more than 5 million Americans are diagnosed with heart value disease. Heart valve disease can occur in any single valve or a combination of the four valves, but diseases of the aortic and mitral valves are the most common. Calcific aortic stenosis is the most common cause of aortic stenosis. Around 1.5 million people in the United States suffer from aortic stenosis, out of which approximately 500,000 among this group of patients suffer from severe aortic stenosis that is an estimated 250,000 patients with severe aortic stenosis. Around 80,000-85,000 aortic valve replacement procedures are performed every year in the U.S.

Rise in prevalence of cardiac disorders:

According to center for disease control and prevention, coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015. In the United States, there is a case of heart attack in every 40 seconds. Every minute, more than one person in the United States dies from a heart disease-related event. It was found that heart disease costs the United States around USD 200 billion each year.

Market Drivers and Restraints:

• Increasing geriatric population.
• Rising prevalence and awareness of HVD
• Regulatory approval and growing demand of prosthetic heart valves
• Government support and funding
• Favorable reimbursement scenario

Frequently Asked Questions?

• What will the market size be in 2024?
• What are the key factors driving the global market?
• What are the challenges to market growth?
• Who are the key players in the market?
• What are the market opportunities and threats faced by the key players?
• What will be the growth rate in 2024?
• Which strategies are used by top players in the Global Prosthetic Heart Valve Market?

Global Competitive Analysis of Prosthetic Heart Valve Market

The global prosthetic heart valve/artificial heart valve market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes prosthetic heart valve/ artificial heart valve market shares for global, Europe, North America, Asia Pacific, and South America.

Inquiry before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prosthetic-heart-valve-market

Key Market points:

Rise in incidence of heart diseases such as aortic stenosis and adoption of prosthetic valves is driving the growth of the prosthetic valves market. Other factors such as advanced technological development and rise of aging population also fuel the market growth.

Intense competition among the players results into high R&D for innovated products such as use of more noninvasive procedure, open heart surgery. For the improvement of healthcare sector, government is also supporting by donating more fundsso as to foster the demand for this particular market. However, some of the stringent regulations made by the government in particular regions may hinder the growth of this market.

Top Competitors of Market: Global Prosthetic Heart Valve Market

• Boston Scientific Corporation (U.S.),
• Medtronic (Ireland),
• Edwards Lifesciences Corporation (U.S.),
• St. Jude Medical,
• LLC. (U.S.),
• Jenavalve Technology, Inc. (Germany),
• LivaNova PLC (U.K.),
• CryoLife, Inc. (U.S.),
• SYMETIS (Switzerland),
• BraileBiomédica (Brazil),
• TTK Healthcare (India),
• Lepu Medical Technology Co.,
• Ltd. (China),
• Colibri Heart Valve,
• LLC (U.S.)
• Abbott (U.S.),

Speak to Analyst @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-prosthetic-heart-valve-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prosthetic Heart Valve Market growing at a CAGR of 12.70% by 2024 - Boston Scientific, Boston Scientific Cardiology, CryoLife, Medtronic, Edwards Lifesciences, Symetis, Braile Biomédica, Colibri Heart Valve, Abbott and others here

News-ID: 1141158 • Views:

More Releases from Data Bridge Market Research

Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 to 2029
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period. Market Overview This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031. Market Overview Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind
Radiology market registering a CAGR of 6.20% during the forecast period of 2022-2029
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Market Overview Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an